These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 15679252)

  • 1. [Chemoradiation for pancreatic adenocarcinoma].
    Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy, combined radiochemotherapy and new therapeutic approaches in adenocarcinoma of the pancreas].
    André T; Balosso J
    J Chir (Paris); 1999 Dec; 136(6):309-17. PubMed ID: 10675820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.
    Regine WF; Winter KA; Abrams RA; Safran H; Hoffman JP; Konski A; Benson AB; Macdonald JS; Kudrimoti MR; Fromm ML; Haddock MG; Schaefer P; Willett CG; Rich TA
    JAMA; 2008 Mar; 299(9):1019-26. PubMed ID: 18319412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer -- feasible and effective].
    Wilkowski R; Thoma M; Heinemann V; Rau HG; Wagner A; Stoffregen C; Dühmke E
    Strahlenther Onkol; 2003 Feb; 179(2):78-86. PubMed ID: 12590317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas.
    Kachnic LA; Shaw JE; Manning MA; Lauve AD; Neifeld JP
    Int J Cancer; 2001 Apr; 96(2):132-9. PubMed ID: 11291097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemoradiation to convert locally advanced pancreatic body adenocarcinoma to resectable disease.
    Cunningham SC; Cusnir M; Burdick RK; Van Echo DA; Moesinger R
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):741-2; discussion 743. PubMed ID: 16258479
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy, chemoradiotherapy or observation after complete resection of pancreatic adenocarcinoma?].
    Lluís F
    Gastroenterol Hepatol; 2009 Feb; 32(2):120-1. PubMed ID: 19231687
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prognosis of pancreatic adenocarcinoma].
    Escourrou J; Buscail L; Pages P; Moreau J; Faure P
    Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C30-3. PubMed ID: 11787377
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma.
    Landry J; Catalano PJ; Staley C; Harris W; Hoffman J; Talamonti M; Xu N; Cooper H; Benson AB
    J Surg Oncol; 2010 Jun; 101(7):587-92. PubMed ID: 20461765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemoradiation in pancreatic carcinoma].
    Claude L; Mornex F
    Cancer Radiother; 2003 Aug; 7(4):254-65. PubMed ID: 12914858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemoradiation for pancreatic cancer: few good data, much debate.
    Twombly R
    J Natl Cancer Inst; 2008 Dec; 100(23):1670-1. PubMed ID: 19033566
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy in adenocarcinomas of the pancreas].
    Huguier M
    Gastroenterol Clin Biol; 2002 Nov; 26(11):1063; discussion 1063-4. PubMed ID: 12483149
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pancreatic cancer--diagnostics and therapy].
    Schramm H
    Zentralbl Chir; 2003 May; 128(5):367. PubMed ID: 12813632
    [No Abstract]   [Full Text] [Related]  

  • 14. Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma.
    Reni M; Cereda S; Balzano G; Passoni P; Rognone A; Zerbi A; Nicoletti R; Mazza E; Arcidiacono PG; Di Carlo V; Villa E
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1253-9. PubMed ID: 19381632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant treatment of oesophageal adenocarcinoma.
    Robb WB; Naughton P; Walsh TN
    Minerva Chir; 2004 Oct; 59(5):461-70. PubMed ID: 15494673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine doublets in advanced pancreatic cancer: should we move on?
    Rocha Lima CM; Flores AM
    J Clin Oncol; 2006 Jan; 24(3):327-9. PubMed ID: 16344312
    [No Abstract]   [Full Text] [Related]  

  • 17. Survival for patients with pancreatic cancer after addition of gemcitabine to fluorouracil chemoradiation.
    Vikram B
    JAMA; 2008 Jun; 299(24):2852; author reply 2852-3. PubMed ID: 18577724
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical update of gemcitabine in pancreas cancer.
    Au E
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():469-73. PubMed ID: 10895197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capecitabine in carcinoma of the pancreas.
    Smith DB; Neoptolemos JP
    Expert Opin Pharmacother; 2006 Aug; 7(12):1633-9. PubMed ID: 16872266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents.
    Pisters PW; Hudec WA; Lee JE; Raijman I; Lahoti S; Janjan NA; Rich TA; Crane CH; Lenzi R; Wolff RA; Abbruzzese JL; Evans DB
    J Clin Oncol; 2000 Feb; 18(4):860-7. PubMed ID: 10673529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.